News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
282,959 Results
Type
Article (15388)
Company Profile (300)
Press Release (267271)
Section
Business (84801)
Career Advice (165)
Deals (14287)
Drug Delivery (34)
Drug Development (52621)
Employer Resources (31)
FDA (6387)
Job Trends (5446)
News (154048)
Policy (11002)
Tag
Academia (990)
Alliances (23113)
Alzheimer's disease (786)
Approvals (6365)
Artificial intelligence (68)
Bankruptcy (100)
Best Places to Work (4780)
Biotechnology (245)
Breast cancer (109)
Cancer (887)
Cardiovascular disease (70)
Career advice (145)
CAR-T (70)
Cell therapy (214)
Clinical research (42044)
Collaboration (287)
Compensation (122)
COVID-19 (1088)
C-suite (79)
Cystic fibrosis (72)
Data (994)
Diabetes (82)
Diagnostics (1438)
Earnings (31180)
Events (49488)
Executive appointments (230)
FDA (6748)
Funding (297)
Gene editing (63)
Gene therapy (162)
GLP-1 (314)
Government (1143)
Healthcare (7107)
Infectious disease (1129)
Inflammatory bowel disease (99)
IPO (7631)
Job creations (942)
Job search strategy (140)
Layoffs (190)
Legal (1539)
Lung cancer (124)
Lymphoma (58)
Manufacturing (82)
Medical device (3196)
Medtech (3198)
Mergers & acquisitions (6788)
Metabolic disorders (246)
Neuroscience (1029)
NextGen Class of 2024 (2108)
Non-profit (940)
Northern California (1072)
Obesity (135)
Opinion (92)
Parkinson's disease (70)
Patents (63)
People (26420)
Phase I (14613)
Phase II (19439)
Phase III (12572)
Pipeline (371)
Postmarket research (933)
Preclinical (6073)
Radiopharmaceuticals (207)
Rare diseases (205)
Real estate (1594)
Regulatory (9042)
Research institute (988)
Southern California (969)
Startups (2040)
United States (8651)
Vaccines (186)
Weight loss (79)
Date
Today (55)
Last 7 days (450)
Last 30 days (1722)
Last 365 days (21399)
2024 (20875)
2023 (23539)
2022 (28740)
2021 (29385)
2020 (25006)
2019 (17591)
2018 (12863)
2017 (15013)
2016 (13152)
2015 (15770)
2014 (11418)
2013 (8423)
2012 (8569)
2011 (8591)
2010 (8241)
Location
Africa (174)
Asia (20016)
Australia (6937)
California (2434)
Canada (848)
China (201)
Colorado (89)
Connecticut (100)
Europe (40827)
Florida (269)
Georgia (68)
Illinois (147)
Indiana (62)
Kansas (56)
Maryland (321)
Massachusetts (1963)
Michigan (55)
Minnesota (120)
New Jersey (639)
New York (693)
North Carolina (424)
Northern California (1072)
Ohio (81)
Pennsylvania (465)
South America (244)
Southern California (969)
Texas (277)
Washington State (244)
282,959 Results for "specialised therapeutics australia".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Specialised Therapeutics signs exclusive agreement with Ascendis Pharma A/S for distribution and commercialisation of three endocrinology therapies in Australia and select South-East Asia countries
Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd has added three new endocrinology therapies to its specialist portfolio, following an exclusive distribution agreement with Danish company Ascendis Pharma A/S.
January 7, 2024
·
10 min read
Specialised Therapeutics signs exclusive license agreement with CanariaBio for new ovarian cancer therapy
Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd has signed a license deal with Korea-based CanariaBio Inc., acquiring the exclusive license to a new monoclonal antibody therapy for patients with ovarian cancer in Australia, New Zealand and in select Southeast Asian countries.
October 12, 2023
·
5 min read
CAR-T
Interius Gets Go-Ahead for Phase I Trial of In Vivo CAR-T Therapy in Australia
Interius BioTherapeutics has received approval from Australia’s Human Research Ethics Committee to begin the first-in-human trial of an investigational in vivo CAR-T therapy designed to treat B-cell malignancies.
July 10, 2024
·
2 min read
·
Tristan Manalac
Deals
Specialised Therapeutics acquires commercialisation rights to new oral MND therapy
Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd will partner with Netherlands based biotechnology company Treeway BV to commercialise a new therapy to treat Amyotrophic Lateral Sclerosis – the most common form of Motor Neurone Disease - in Australia and New Zealand.
August 27, 2023
·
4 min read
Press Releases
ARS Pharmaceuticals Announces Filings for Approval of neffy® in China, Japan and Australia
December 13, 2024
·
8 min read
Lone Star Bio
Colossal Biosciences’ Thylacine Gene-Editing Technologies Provide Hope for Australia’s Endangered Northern Quoll
Scientists from Colossal Biosciences, the world’s first de-extinction company, and the University of Melbourne announce a major step forward in the effort to save Australia’s endangered northern quoll from the invasive cane toad.
May 8, 2024
·
9 min read
Press Releases
Recce Pharmaceuticals Granted Australia Patent for RECCE® Anti-Infectives
November 27, 2024
·
3 min read
Policy
Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
Axonics, Inc. (Nasdaq: AXNX) today announced that it has received regulatory approval from the Therapeutic Goods Administration (TGA) for marketing the Axonics F15™ recharge-free sacral neuromodulation (SNM) system in Australia to treat adults with overactive bladder.
May 16, 2024
·
6 min read
Press Releases
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
November 12, 2024
·
4 min read
Drug Development
Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia
Oragenics, Inc., a pioneer in developing innovative intranasal pharmaceuticals for neurological disorders, announced a partnership with Avance Clinical, a leading Contract Research Organization, to conduct a Phase II clinical trial in Australia.
May 7, 2024
·
4 min read
1 of 28,296
Next
